Retour
47
50
Fourchette du Jour
62,63 €
65,11 €
Fourchette 52 Semaines
47,50 €
82,22 €
Volume
1 809 170
Moyenne 50J / 200J
71,41 €
/
66,89 €
Clôture Précédente
63,43 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (625 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,4 | 14,0 |
| P/B | 152,0 | 2,4 |
| ROE % | 153,6 | 11,4 |
| Net Margin % | 22,7 | 10,1 |
| Rev Growth 5Y % | 33,2 | 7,0 |
| D/E | 0,0 | 0,5 |
Points Clés
Revenue grew 33,23% annually over 5 years — strong growth
Earnings declined -28,64% over the past year
ROE of 153,59% indicates high profitability
Net margin of 22,69% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 644,59M in free cash flow
Croissance
Revenue Growth (5Y)
33,23%
Revenue (1Y)37,55%
Earnings (1Y)-28,64%
FCF Growth (3Y)31,41%
Qualité
Return on Equity
153,59%
ROIC1254,19%
Net Margin22,69%
Op. Margin58,45%
Sécurité
Debt / Equity
0,00
Current Ratio4,66
Interest Coverage45,03
Valorisation
P/E Ratio
23,41
P/B Ratio151,98
EV/EBITDA8,92
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37,55% | Revenue Growth (3Y) | 29,78% |
| Earnings Growth (1Y) | -28,64% | Earnings Growth (3Y) | 6,08% |
| Revenue Growth (5Y) | 33,23% | Earnings Growth (5Y) | -5,82% |
| Profitability | |||
| Revenue (TTM) | 1,40B | Net Income (TTM) | 316,89M |
| ROE | 153,59% | ROA | 12,55% |
| Gross Margin | 78,13% | Operating Margin | 58,45% |
| Net Margin | 22,69% | Free Cash Flow (TTM) | 644,59M |
| ROIC | 1254,19% | FCF Growth (3Y) | 31,41% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 4,66 |
| Interest Coverage | 45,03 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 23,41 | P/B Ratio | 151,98 |
| P/S Ratio | 5,31 | PEG Ratio | -1,04 |
| EV/EBITDA | 8,92 | Dividend Yield | 0,00% |
| Market Cap | 7,42B | Enterprise Value | 7,28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,40B | 1,02B | 829,25M | 660,12M | 443,31M |
| Net Income | 316,89M | 444,09M | 281,59M | 202,13M | 402,71M |
| EPS (Diluted) | 2,56 | 3,43 | 2,10 | 1,44 | 2,74 |
| Gross Profit | 1,09B | 855,91M | 636,89M | 520,81M | 361,90M |
| Operating Income | 816,29M | 551,48M | 337,57M | 267,53M | 275,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 2,06B | 1,73B | 1,84B | 1,10B |
| Total Liabilities | 2,48B | 1,70B | 1,65B | 1,67B | 907,48M |
| Shareholders' Equity | 48,81M | 363,82M | 83,81M | 169,80M | 196,95M |
| Total Debt | 0,0 | 1,51B | 1,50B | 1,51B | 876,67M |
| Cash & Equivalents | 133,82M | 115,85M | 118,37M | 234,20M | 118,72M |
| Current Assets | 825,21M | 1,09B | 746,42M | 739,01M | 926,29M |
| Current Liabilities | 177,09M | 139,10M | 112,49M | 130,79M | 117,15M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#452 of 1018
Custom
Capital Light Compounder
#69 of 211
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026